L & L Bio Co., Ltd., Ningbo, China
Works in Hematology · Immunology · Oncology · Renal & urogenital · Women's health
L & L Bio Co., Ltd., Ningbo, China is a clinical trial sponsor. It has 3 active clinical trials with 414 planned participants, across 5 therapeutic areas. Since 2021 it has completed 0 trials and stopped 1 early.
Trial track record · since 2021
Pipeline · 3 active trials
| Stage | Trial | Status |
|---|---|---|
Questions about L & L Bio Co., Ltd., Ningbo, China
L & L Bio Co., Ltd., Ningbo, China is lead sponsor of 3 active clinical trials on ClinicalTrials.gov, with 414 planned participants, in Hematology, Immunology, Oncology, Renal & urogenital and other areas. Since 2021 it has completed 0 trials and stopped 1 early.
From public sources only: ClinicalTrials.gov for trials, FDA's Data Dashboard, warning-letter listing and enforcement reports for the FDA record, and SEC filings for financials. Approve Suite is not affiliated with L & L Bio Co., Ltd., Ningbo, China; every record links to the source, and nothing here is advice.
See the rest of this profile
A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.
Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2025-09-17.
Approve Suite is not affiliated with L & L Bio Co., Ltd., Ningbo, China.
See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.